VEON's shares have surged over 340% in three years, dramatically outperforming the market. As the stock hovers around $54, analysts are divided: does this represent a classic value opportunity or a sign that the easy gains are over? We examine the valuation metrics behind the headline numbers.
Shares of GE Vernova (GEV) have surged over 100% in the past year, closing near $726. As the energy transition play captivates the market, analysts are divided on whether its valuation still offers room to run or signals a peak.
Amidst crypto market turbulence, Tether (USDT) maintains its dominance as the leading stablecoin, offering investors a potential harbor and sparking debate over its role in modern finance.
SoFi Technologies dazzles with its first $1 billion revenue quarter and a push into crypto payments, but a stark valuation gap has emerged, raising questions about whether its stock price has already outpaced its growth narrative.
The Texas-born travel center giant Buc-ee's is renowned for massive stores and spotless restrooms. But its most disruptive industry practice might be its pay scale, which far exceeds typical convenience store wages and fuels intense competition for jobs.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
Opera's stock surged following the announcement of expanded Tether (USDT and XAUT) integration in its MiniPay wallet, which processed over $153M in stablecoin transactions in December and aims to simplify crypto access for its 12.6 million users in emerging economies.
As cargo theft evolves from petty crime to sophisticated, high-value scams, logistics firms like Echo Global Logistics are deploying advanced AI and human vigilance in a high-stakes battle for security. Senior VP Jeff Starr details the new frontline in freight fraud.
As artificial intelligence reshapes finance, we examine whether XRP's underlying technology is built to capitalize on the trend of 'agentic AI' handling transactions, or if its potential benefits remain speculative.
As global leaders gather in Davos, a coalition of over 400 affluent individuals from 24 nations issues a stark demand: governments must impose higher taxes on the ultra-wealthy to tackle inequality.
CNBC's Jim Cramer offered a mixed review of ServiceNow, praising its management and cloud platform while expressing deep frustration with the stock's recent performance, calling it a 'nightmare' for investors.
CNBC's Jim Cramer offered a measured take on data security firm Rubrik (NYSE:RBRK), suggesting investors wait for market volatility to settle before considering a position, while highlighting the crowded nature of the sector.
CNBC's Jim Cramer reaffirms his bullish stance on NVIDIA, calling the chipmaker the dominant force in the rapidly evolving artificial intelligence landscape, while analysts debate the sustainability of its market position.
CNBC's Jim Cramer concedes he misjudged the explosive demand for Apple's iPhone 17, which powered the tech giant to a staggering earnings beat that caught Wall Street off guard.
Despite modest nominal gains, real wages for U.S. workers are failing to keep pace with the cost of living, with a majority reporting financial strain as structural economic shifts and technological efficiencies redirect gains away from paychecks.
Despite its dominance and a recent surge to over 325 million subscribers, Netflix faces mounting criticism over pricing, content decisions, and user experience. An analysis of consumer feedback reveals the key frustrations testing viewer loyalty in an increasingly competitive streaming landscape.
Six Flags Entertainment's shares have tumbled nearly 60% over the past year, trading far below industry peers. A deep dive into its valuation metrics reveals a significant discount, but questions remain about its path to recovery in a shifting leisure landscape.
As the ASX braces for a turbulent February amid rate hike fears, a closer look reveals resilient micro-caps with unique value propositions. We analyze three sub-$150M companies—from healthcare tech to critical minerals—that are navigating the volatility with strong balance sheets and niche market positions.
The surge in popularity of weight-loss drugs like Ozempic and Wegovy is sending shockwaves far beyond the pharmacy, fundamentally altering consumer spending, challenging major corporations, and forcing a broad economic recalibration.
Capital Management Corp's significant stake increase in investment bank Moelis & Company is being viewed by market observers as a strategic wager on a potential rebound in mergers and acquisitions activity.
